Disposable wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device

Abstract
A disposable, wearable, self-contained insulin dispensing device includes a housing and an insulin source in the housing that is connected to a catheter for injecting insulin into a user. The catheter projects generally perpendicularly to a generally planar surface of the housing configured for abutting a skin surface of the user; which planar surface includes an adhesive layer for adhering the housing surface to the skin surface. A removable release sheet covers the adhesive layer for protecting the adhesive layer prior to use of the device. The release sheet is provided with a catheter protection element to enclose and protect an end portion of the catheter, such that removal of the release sheet for exposing the adhesive layer also exposes the end portion. A pump in the housing includes an actuator employing a shape memory alloy wire.
Description
BACKGROUND OF THE INVENTION

The present invention relates generally to wearable insulin dispensing devices.


In connection with injection of insulin for combatting Type I and Type II Diabetes extremely important features are simplicity of operation, reliability, cost and flexibility, which all are related to the issue of compliance which particularly in the cases of relatively mild Type II diabetes is a problem with important consequences regarding the success rate in treating the patients.


SUMMARY OF THE INVENTION

The main object of the invention is to provide a wearable insulin dispensing device having features and operation characteristics supporting and easing compliance by the users of the device.


The present invention provides a disposable, wearable, self-contained insulin dispensing device comprising

  • a housing,
  • an insulin source in said housing,
  • a pump means in said housing and adapted for pumping insulin from said insulin source to a catheter for injection of said insulin in a user of the device and, said catheter being associated with said housing and projecting generally perpendicularly to a generally planar surface of said housing intended for abutting a skin surface of a user of the device,
  • an adhesive layer provided on said planar surface for adhering said planar surface to said skin surface, and
  • a removable release sheet covering said adhesive layer for protecting said adhesive layer prior to use of said dispensing device, said release sheet being provided with catheter protection means to enclose and protect an end portion of said catheter such that removal of said release sheet for exposing said adhesive layer exposes said end portion.


Hereby, in a simple, reliable and cost-effective manner a device is provided which is easy to apply and still in an effective manner protects the catheter against damage and contamination until use of the device is initiated.


In another aspect, the invention provides a disposable, wearable, self-contained insulin dispensing device comprising

  • a housing,
  • an insulin source in said housing,
  • a pump means in said housing and adapted for pumping insulin from said insulin source to a catheter for injection of said insulin in a user of the device and, said catheter being associated with said housing and projecting generally perpendicularly to a generally planar surface of said housing intended for abutting a skin surface of a user of the device,
  • an adhesive layer provided on said planar surface for adhering said planar surface to said skin surface,
  • a combined microphone and loudspeaker associated with said housing, preferably arranged inside said housing, and
  • recording and play back means connected to said combined microphone and loudspeaker and associated with said housing, preferably arranged inside said housing, such that verbal messages may be recorded and played back by said dispensing device.


Hereby a device promoting simple communication between a health care provider and the user is provided with readily understandable operation and with good effect on the compliance rate.


In yet another aspect, the invention provides a disposable, wearable, self-contained insulin dispensing device comprising

  • a housing,
  • an insulin source in said housing,
  • a pump means in said housing and adapted for pumping insulin from said insulin source to a catheter for injection of said insulin in a user of the device, and
  • an actuator for said pump means, said actuator comprising a shape memory alloy wire, said actuator preferably further comprising a ratchet gear or pawl wheel, a pawl adapted for cooperating with said pawl wheel and connected to one end of said shape memory alloy wire and a spring means connected to said pawl, the connections between said pawl and said wire and said pawl and said spring means being such that contraction of said wire rotates said pawl wheel against the spring force of said spring means.


Hereby a pump means requiring very low energy and with a high degree of reliability is provided at a relatively low cost.


In a yet further aspect, the invention relates to a disposable, wearable, self-contained insulin dispensing device comprising

  • a housing,
  • an insulin source in said housing,
  • a pump means in said housing and adapted for pumping insulin from said insulin source to a catheter for injection of said insulin in a user of the device,
  • an actuator for said pump means, preferably an actuator comprising a shape memory alloy wire, and
  • controlling means for controlling the operation of said actuator according to a program, said program consisting in a sequence of a certain amount of actuations of said actuator per 24 hour time periods, or, in connection with provision of a timing means connected to said controlling means said program consisting in a sequence of actuations of said actuator that varies according to the time of day or, in connection with provision of a timing means connected to said controlling means and an input device for inputting data to said controlling means, adapting said controlling means so as to be programmable by means of said data, or adapting said program of said controlling means to comprises algorithms for automatically altering the sequence of actuations of said actuator according to input of data relative to actual glucose level in the blood of the use of the device and/or intake of nutrients by said user.


Hereby, compliance is enhanced by providing a device with capabilities of rendering a very specific and well-tuned dosage which may be altered according to the specific development of the individual user.


In a yet further aspect, the invention relates provides a combination of a dispensing device as specified above and a programming controller, said dispensing device and said programming controller comprising cooperating transmission and/or receiving means for mutual communication of data, said programming controller preferably being a cellular telephone or a personal computer or a laptop computer or a hand held computer.


Moreover, the invention provides a method of controlling the operation of a disposable, wearable, self-contained insulin dispensing device comprising

  • a housing,
  • an insulin source in said housing,
  • a pump means in said housing and adapted for pumping insulin from said insulin source to a catheter for injection of said insulin in a user of the device,
  • an actuator for said pump means, preferably an actuator comprising a shape memory alloy wire, and
  • controlling means for controlling the operation of said actuator according to a program,


    said method comprising the steps of:
  • providing said controlling means with data for generating and/or amending said program prior to and/or after initiation of use of said dispensing device.


Furthermore, in a yet other aspect, the invention also related to a method of controlling the operation of a disposable, wearable, self-contained insulin dispensing device comprising

  • a housing,
  • an insulin source in said housing,
  • a pump means in said housing and adapted for pumping insulin from said insulin source to a catheter for injection of said insulin in a user of the device and, said catheter being associated with said housing and projecting generally perpendicularly to a generally planar surface of said housing intended for abutting a skin surface of a user of the device,
  • an adhesive layer provided on said planar surface for adhering said planar surface to said skin surface,
  • a combined microphone and loudspeaker associated with said housing, preferably arranged inside said housing,
  • recording and play back means connected to said combined microphone and loudspeaker and associated with said housing, preferably arranged inside said housing, such that verbal messages may be recorded and played back by said dispensing device, an
  • manual operating means for manually controlling the operation of said dispensing device


    said method comprising the steps of:
  • recording verbal instructions in said recording means for instructing the user of the device in the operation of said dispensing device, and
  • playing back said verbal instructions.


Finally, the invention relates to a method of controlling the operation of a disposable, wearable, self-contained insulin dispensing device comprising

  • a housing,
  • an insulin source in said housing,
  • a pump means in said housing and adapted for pumping insulin from said insulin source to a catheter for injection of said insulin in a user of the device and, said catheter being associated with said housing and projecting generally perpendicularly to a generally planar surface of said housing intended for abutting a skin surface of a user of the device,
  • an adhesive layer provided on said planar surface for adhering said planar surface to said skin surface,
  • a combined microphone and loudspeaker associated with said housing, preferably arranged inside said housing,
  • a programmable computing means associated with said housing, preferably arranged inside said housing, and
  • signal conversion means connected to said combined microphone and loudspeaker and associated with said housing, preferably arranged inside said housing, and adapted for converting received audio signals into input signals for said computing means and for converting output signals from said computing means to audio signals,


    said method comprising the steps of:
  • transmitting audio signals to said microphone for controlling the operation of said dispensing device,
  • receiving audio signals from said loudspeaker for evaluating the operation of said dispensing device.





BRIEF DESCRIPTION OF THE DRAWINGS

In the following, the invention will be described and explained more in detail in connection with a currently preferred insulin dispensing device according to the invention shown, solely by way of example, in the accompanying drawings where:



FIG. 1 is a schematic isometric view of a disposable insulin dispensing device according to the invention before the adhesive pad for adhering the device to a user has been mounted on the device,



FIG. 2 is a schematic isometric view of the device of FIG. 1 seen from another angle and with the adhesive pad mounted thereon,



FIG. 3 is a schematic isometric partly exploded view of the device of FIG. 2,



FIG. 4 is a schematic entirely exploded view of the device of FIG. 2,



FIG. 5 is a schematic isometric view of the device of FIG. 2 together with a programming device according to the invention,



FIG. 6 is a schematic enlarged scale exploded view of a shape memory alloy actuator mechanism according to the invention of the device of FIG. 2, and



FIG. 7 is a schematic view corresponding to FIG. 6 with the elements of the shape memory actuator shown in interconnected operative relative positions.





DETAILED DESCRIPTION OF THE INVENTION

Referring now to FIG. 1, a disposable insulin dispensing device according to the invention, generally referenced by the numeral 1, comprises a water-tight generally cylindrical housing 2 provided with a push button 3 for activating and deactivating the device as well as for activating a so-called bolus operation as explained in the following.


The housing further comprises a transparent window 4 for inspecting the operation of the device and apertures 5 for transmission of sound waves as explained in the following.


At one end of the housing 2 there is provided a stiletto 6 having a sharp needle 7 extending through a catheter 8 connected to a not shown insulin container or capsule inside the housing 2 as explained in the following.


Referring now to FIGS. 2-3, the housing 2 is fixedly received in a trough 9 of an adhesive pad 10 made of a combination of a plate 11 of skin-friendly adhesive material, for instance as well known in the field of ostomy pouches, see for instance European patent application no. 0413250 and European patent application no. 0092999, and a relatively compressible portion 10a made of foam material attached to the plate 11. The catheter 8 extends through the planar portion 11 of the pad 10. The push button 3 is protected by the foam material 10a so as to avoid inadvertent operation of the button for instance when the user is asleep.


A slip release film 12 is adhered to the bottom surface of the adhesive plate 11 for protecting the adhesive surface of the plate 11 such that the adhesive properties are intact when the pad is to be adhered to the skin of a user of the dispensing device. The release film 12 is provided with a protective hollow projection 13 for receiving the catheter 8 and the needle 7 of the stiletto 6 so that the needle 7 and the catheter 8 are protected by the projection 13 before use of the dispensing device 1. The housing 2 is provided with and end cover 14 on which the catheter 8 is mounted by means of a communication bushing 15 provided with an internal not shown elastomer mass and a communication passage for communicating the catheter 8 with the interior of the housing 2 as explained in the following in connection with FIG. 4.


In use, the user removes the protective release sheet 12 thereby exposing the tip of the needle 7 such that the needle may be inserted subcutaneously at the same time that the adhesive pad 10a, 11 is adhered to the abdominal skin of the user. When the needle 7 and the catheter 8 have been inserted subcutaneously and the device has been adhered to the skin of the user, the stiletto 6 is removed whereby communication is established between the catheter 8 and the interior of the housing 2 for supplying insulin subcutaneously to the user of the device.


The elastomer mass in the bushing 15 seals the exit opening of the needle 7 when it is removed such that no insulin may leak through said exit opening but is constrained to flow solely from the capsule to the catheter 8.


Referring now to FIG. 4 showing an exploded view of the components of the insulin dispensing device according to the invention, the housing 2 contains a container or a capsule 16 for storing and dispensing insulin. The container or capsule 16 is of a well-known type having a perforatable dispensing projection 17 for receiving a catheter 18 for communicating the interior of the container 16 with the catheter 8 through the communication bushing 15 when the needle 7 has been retracted from said elastomer mass inside the bushing 15 as explained above.


A spindle 19 provided with a piston 20 is received in the container 16 such that axial displacement of the spindle towards the dispensing projection 17 will press insulin through the catheter 18 to the catheter 8. The spindle 19 is rotated and displaced by means of a shape memory alloy actuator described more in detail in the following with reference to FIG. 6.


A battery 21 for supplying power to the shape memory actuator is provided adjacent an end cover 22 of the housing 2.


The shape memory actuator comprises a pawl or ratchet wheel 23, a guide bushing 24, a spring wheel 25 and a shape memory wire 26. The operation of the shape memory actuator will be described more in detail in the following with reference to FIGS. 6 and 7.


A printed circuit board 27 is provided for controlling the function of the dispensing device and the various operational steps thereof as described in the following.


Finally a combined microphone/loudspeaker 28 is arranged inside the housing 2 adjacent the apertures 5 for receiving and emitting sound waves for the purposes described below.


Referring now to FIG. 5, a programming device or controller 29 having programming keys 30 and a display 31 is shown proximate the dispensing device for communicating with a not shown receiver/transmitter arranged inside the housing 2. The communication may take place by infra red signals or other suitable signals transmitted from and to an opening 32 leading to a transmitter/receiver inside the controller 29 to and from, respectively an opening 33 (see FIG. 2) in the end cover 22 of the housing 2 leading to said not shown transmitter/receiver inside the housing 2.


Referring now to FIGS. 6 and 7, the spindle 19 is displaced axially in the direction of the arrow R1 by counter-clockwise rotation of the pawl wheel 23 in the direction of the R2 whereby the thread 36 meshing with the internal thread 37 results in said axial displacement whereby the piston 20 is displaced further into the carpule 16 to dispense insulin through the catheter 18 to the catheter 8 (FIG. 4).


Rotation of the pawl wheel 23 is accomplished by means of the shape memory alloy (for instance Nitinol) wire 26 attached to electrically conductive rods 38 and 39 that are fixed in recesses 40 and 41, respectively, in the electrically non-conductive guide bushing 24 and the electrically conductive spring wheel 25, respectively.


The recess 40 is provided with not shown electrical contacts for electrically connecting the rod 39 to the battery 21 for supplying electrical current to the shape memory alloy (SMA) wire 26 to heat it in a manner and sequence controlled by the program elements in the printed circuit board 27.


The spring wheel 25 has U-shaped spring arms 44 and 45 for exerting a spring force on the ends 46 and 47 thereof, respectively, in a direction towards the center of the pawl wheel 23 such that the ends 46 and 47 are constantly biased to enter into engagement with the teeth of the pawl wheel 23.


The stop pins 42 and 43 are electrically connected to the printed circuit board 27 for emitting an electrical signal thereto when the spring wheel arm 48 contacts said stop pins.


The rod 38 is as mentioned above electrically connected to the power source such that an electrical current may be passed through the rod 38, the wire 26, the rod 39, the loop recess 41 and the spring wheel 25 to heat the wire 26 to cause the wire to contract and rotate the pawl wheel the distance of one tooth in the direction of arrow R2 by means of the arm end 46 engaging a tooth of the wheel until the arm 48 contacts the stop pin 42 that emits a signal to the control printed circuit board 27 whereby the current through the wire 26 is interrupted and the SMA wire 26 cools off and expands.


The other arm end 47 engages a tooth of the wheel 23 as a pawl and prevents the wheel 23 from rotating clock-wise. The spring effect of the spring wheel 25 in the tangential direction causes the arm 42 to move back into contact with the stop pin 43 thereby tightening the expanded SMA wire 26.


The signals from the stop pins 42 and 43 are also utilized to indicate correct functioning of the pump and as an indication of the number of doses administered through the catheter 8.


A dispensing device or insulin pump according to the invention may function in several different manners depending on the design and programming of the various control elements of the circuit board 27:


1. Stand Alone Pump with Constant Flow:


The pump functions as a constant flow pump and may be designed for different flow rates, for instance 20 units/24 hours, 30 units/24 hours, etc. By depressing the bolus button 3 and holding it down, the pumping program is initiated and by again pressing the button 3 down and holding it, the pumping program is terminated while a short duration pressure on the bolus button 3 activates a bolus additional dosage of insulin of a certain magnitude.


2. Stand Alone Pump with Varying Flow:


A timing device is incorporated in the printed circuit board 27 so that a standard program controls the flow dispensed by the pump during recurring 24 hour periods. The pre-programmed operating instructions may for example result in a lower dosage at night than during the day and an extra dosage at mealtimes.


3. Programmable Pump Type 1:


The pump is not provided with a predetermined program, but is provided with a programmable unit in the printed circuit board 27 and can be programmed by the user or a doctor by means of a controller 29. The programming must be able to take place through the packing material in which the dispensing device is supplied so that the user can transport the device in a sterilized out packaging on vacations or the like without having to carry the controller along. The controller is a dedicated unit that for instance via a USB plug can be connected to a PC or it can be provided with cellular telephone capability for transmission of data. The controller can thus be programmed by a doctor or a user and be used for programming of the functioning of all subsequently used disposable dispensing devices.


4. Programmable Pump Type 2:


This pump functions in the same manner as programmable pump type 1, but the controller is a personal data device such as the type marketed under the trademark PALM PILOT®, or a laptop PC. This gives the additional advantage that the user may input health information and glucose level measurement results directly into the controller or programming unit and thus communicate such information to the doctor who may use this information when deciding whether the programming function of the controller or the programming unit is to be altered for subsequently used disposable dispensing devices.


5. Programmable Pump with Audio Input and Output:


By providing the dispensing device with the microphone/loudspeaker 28 and a suitable recording/play-back chip in the printed circuit 27, short messages may be recorded by the dispensing device, and the short messages may be emitted by the device upon suitable manipulation of the bolus push button 3 or a separate recording button (not shown) mounted on the housing 2.


By means of this audio capability the user may record verbally formulated information regarding glucose levels, meal composition, exercise, etc. A timer may record the timing of each recorded message. A doctor may then use these recorded messages together with information about number and timing of bolus dosages, pumping stops and the program utilized for the dispensing of the insulin so as to evaluate the treatment and decide upon any changes in the programming and instructions to the patient which may be recorded by the doctor via a mobile telephone or the like such that messages are automatically delivered to the user at predetermined times. Such a message could for example be ‘remember to measure your glucose level’ (message program to be delivered by the dispensing device to the user each morning at 8 o'clock) and so on.


Furthermore, standard instructions can be included in the programming circuit so that the pump may deliver verbal messages to the user instead of audio signals such as beep sounds. The message could for instance be: ‘Pump is stopped’ or ‘This is your third bolus in a row and you have taken a total of eight bolus dosages today’ or ‘The pump will be empty in two hours’ and so on. Generally speaking, the audio capability described above will render the dispensing device provided with such capability much more user-friendly, especially for users initiating a treatment or not very disciplined as regards compliance.


6. Closed Loop Re-Programmable Pump:


Either the controller or the computing unit mounted in the printed circuit 27 may be programmed to react to information regarding actual glucose blood level inputted by the user perhaps together with other information, such as data regarding the timing and constitution of the last meal, to alter the programme program of the dispensing flow or dosage to take into consideration this information such that the dispensing device to a certain extent constitutes a closed loop, fuzzy logic, semi-automatic self re-programming insulin dispensing device.


The programming controller 29 may be a mobile wire-less communication device such as a cellular telephone communicating with the dispensing device by audio signals transmitted to and received from the transmitter/receiver 28. The transmissions should be preceded and terminated by an identification code to avoid disruption of the programming of the device by extraneous audio signals. Other signal identification or protection procedures such as encryption may be utilized. The audio signals may be converted to controlling signals for altering the programming of the re-programmable computing unit mounted in the circuit board 27.


Signal conversion means may be provided for converting the audio signals received by the receiver into input signals for the computing means and for converting output signals from the computing means into audio signal for being transmitted by the loudspeaker.


So-called SMS signals may also be utilized for transferring information between a wire-less mobile communications unit and the dispensing device, for instance by means of IR signals or so-called Bluetooth communication technology.


Although the basic concept of the invention is that the entire device is disposable, a variation may be that the receiver/transmitter unit 28 with recording and play back components and corresponding battery and perhaps circuit board with computing means is reusable and may be releasably received in a holder provided on the disposable portion of the device.

Claims
  • 1. A disposable pump device for dispensing insulin, comprising: a wearable pump housing that defines a space to receive a separate container;an insulin container that is insertable into the space defined by the wearable pump housing, the insulin container having a perforatable dispensing end through which insulin is to be dispensed;a piston rod comprising screw threads on an outer surface portion, the piston rod being movably arranged in the wearable pump housing to dispense the insulin from the insulin container when the insulin container is inserted in the wearable pump housing;a drive system to advance the piston rod toward the insulin container and thereby dispense the insulin when the insulin container is inserted in the wearable pump housing; anda battery to supply electrical power for operation of the disposable pump device, the battery being positioned inside the wearable pump housing,wherein the entire pump device is disposable and non-reusable.
  • 2. The device of claim 1, wherein the disposable pump device communicates with a controller device having buttons and a display.
  • 3. The device of claim 2, wherein the disposable pump device communicates with a controller device via wireless communication signals.
  • 4. The device of claim 2, wherein the controller device comprises at least one of a cellular phone device, a personal computer device, a laptop computer device, or a handheld computer device.
  • 5. The device of claim 1, further comprising a button interface associated with the wearable pump housing that is configured to activate a bolus operation for dispensing the insulin from the insulin container.
  • 6. The device of claim 1, wherein the wearable pump housing is water-tight when the insulin container is inserted in the is received in the wearable pump housing.
  • 7. The device of claim 1, further comprising a catheter to communicate the insulin dispensed from the insulin container into a user.
  • 8. The device of claim 7, wherein the catheter projects generally perpendicular to a generally planar surface of the pump housing, further comprising an adhesive layer coupled to the generally planar surface of the pump housing to adhere the pump housing to skin of the user.
  • 9. The device of claim 8, further comprising a removable release sheet to cover the adhesive layer, the release sheet including a catheter protection structure that at least partially encloses an end portion of the catheter when the release sheet covers the adhesive layer.
  • 10. The device of claim 1, wherein the drive system comprises a gear wheel, a pawl arranged to engage at least one tooth of the gear wheel, and a spring device coupled to the pawl so as to urge the pawl to rotate the gear wheel.
  • 11. The device of claim 1, wherein the drive system includes a shape memory alloy actuator.
  • 12. The device of claim 1, wherein the wearable pump housing is wearable on the skin of a user.
  • 13. The device of claim 1, further comprising a transparent window portion arranged on the wearable pump housing to view the insulin container when the insulin container is inserted in the wearable pump housing.
  • 14. The device of claim 1, wherein the wearable pump housing of the disposable pump device is wearable on a user's body and dispenses insulin to the user via a catheter tube while a handheld controller device having a user-interface buttons and a display communicates with the disposable pump device.
  • 15. The device of claim 14, wherein the wearable pump housing is water-tight when the insulin container received the wearable pump housing outputs insulin through the catheter tube to the user.
  • 16. The device of claim 15, wherein the insulin container is viewable through a generally transparent window portion disposed on the wearable pump housing when the disposable pump device dispenses insulin to the user via the catheter tube.
  • 17. The device of claim 16, wherein the handheld controller device receives user input indicative of glucose level measurement results.
  • 18. The device of claim 1, wherein the wearable pump housing defines the space to slidably receive a generally cylindrical container through an opening in the wearable pump housing, wherein the piston rod comprises a generally cylindrical body portion having the screw threads on the outer surface portion of the generally cylindrical body portion, wherein the drive system is positioned inside the wearable pump housing, and wherein the wearable pump housing includes one or more structures that hinder removal of the insulin container and connection with a subsequent insulin container.
  • 19. The device of claim 18, wherein the disposable pump device communicates with a controller device having buttons and a display.
  • 20. The device of claim 18, wherein the disposable pump device dispenses insulin to the user at a new dosage rate in response to user input indicative of glucose level measurement results.
  • 21. The device of claim 18, further comprising a button interface associated with the wearable pump housing that is configured to activate a bolus operation for dispensing the insulin from the insulin container.
  • 22. The device of claim 18, wherein the drive system comprises a gear wheel, a pawl arranged to engage at least one tooth of the gear wheel, and a spring device coupled to the pawl so as to urge the pawl to rotate the gear wheel.
  • 23. The device of claim 18, wherein the wearable pump housing of the disposable pump device is wearable on a user's body and dispenses insulin to the user via a catheter tube while a handheld controller device having a user-interface buttons and a display communicates with the disposable pump device, wherein the insulin container is viewable through a generally transparent window portion disposed on the wearable pump housing when the disposable pump device dispenses insulin to the user via the catheter tube.
  • 24. A disposable pump device for dispensing insulin, comprising: a wearable pump housing that defines a space to receive a separate container;an insulin container that is insertable into the space defined by the wearable pump housing, the insulin container having a perforatable dispensing end through which insulin is to be dispensed;a piston rod comprising screw threads on an outer surface portion, the piston rod being movably arranged in the wearable pump housing to dispense the insulin from the insulin container when the insulin container is inserted in the wearable pump housing;a drive system to advance the piston rod toward the insulin container and thereby dispense the insulin when the insulin container is inserted in the wearable pump housing; anda battery to supply electrical power for operation of the disposable pump device, the battery being positioned inside the wearable pump housing,wherein the entire pump device is disposable and non-reusable,wherein the wearable pump housing of the disposable pump device is wearable on a user's body and dispenses insulin to the user via a catheter tube while a handheld controller device having a user-interface buttons and a display communicates with the disposable pump device,wherein the wearable pump housing is water-tight when the insulin container received the wearable pump housing outputs insulin through the catheter tube to the user,wherein the insulin container is viewable through a generally transparent window portion disposed on the wearable pump housing when the disposable pump device dispenses insulin to the user via the catheter tube, andwherein the handheld controller device that is connectable to a computer for transmission of data.
  • 25. The device of claim 24, further comprising a button interface associated with the wearable pump housing that is configured to activate a bolus operation for dispensing the insulin from the insulin container.
  • 26. The device of claim 24, wherein the drive system comprises a gear wheel, a pawl arranged to engage at least one tooth of the gear wheel, and a spring device coupled to the pawl so as to urge the pawl to rotate the gear wheel.
  • 27. A disposable pump device for dispensing insulin, comprising: a wearable pump housing that defines a space to receive a separate container;an insulin container that is insertable into the space defined by the wearable pump housing, the insulin container having a perforatable dispensing end through which insulin is to be dispensed;a piston rod comprising screw threads on an outer surface portion, the piston rod being movably arranged in the wearable pump housing to dispense the insulin from the insulin container when the insulin container is inserted in the wearable pump housing;a drive system to advance the piston rod toward the insulin container and thereby dispense the insulin when the insulin container is inserted in the wearable pump housing; anda battery to supply electrical power for operation of the disposable pump device, the battery being positioned inside the wearable pump housing,wherein the entire pump device is disposable and non-reusable,wherein the wearable pump housing of the disposable pump device is wearable on a user's body and dispenses insulin to the user via a catheter tube while a handheld controller device having a user-interface buttons and a display communicates with the disposable pump device,wherein the wearable pump housing is water-tight when the insulin container received the wearable pump housing outputs insulin through the catheter tube to the user,wherein the insulin container is viewable through a generally transparent window portion disposed on the wearable pump housing when the disposable pump device dispenses insulin to the user via the catheter tube,wherein the handheld controller device receives user input indicative of glucose level measurement results, andwherein the disposable pump device dispenses insulin to the user at a new dosage rate in response to the user input indicative of glucose level measurement results.
  • 28. The device of claim 27, further comprising a button interface associated with the wearable pump housing that is configured to activate a bolus operation for dispensing the insulin from the insulin container.
  • 29. The device of claim 27, wherein the drive system comprises a gear wheel, a pawl arranged to engage at least one tooth of the gear wheel, and a spring device coupled to the pawl so as to urge the pawl to rotate the gear wheel.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a Continuation of co-pending International Application No. PCT/DK2003/000753, filed Nov. 4, 2003, the disclosure of which is incorporated herein by reference.

US Referenced Citations (229)
Number Name Date Kind
2605765 Kollsman Aug 1952 A
3171412 Braun Mar 1965 A
3886938 Szabo et al. Jun 1975 A
4077405 Haerten et al. Mar 1978 A
4231368 Becker Nov 1980 A
4265241 Portner et al. May 1981 A
4300554 Hessberg et al. Nov 1981 A
4313439 Babb et al. Feb 1982 A
4398908 Siposs Aug 1983 A
4435173 Siposs et al. Mar 1984 A
4443218 DeCant, Jr. et al. Apr 1984 A
4493704 Beard et al. Jan 1985 A
4529401 Leslie et al. Jul 1985 A
4850817 Nason et al. Jul 1989 A
5045064 Idriss Sep 1991 A
5088981 Howson et al. Feb 1992 A
5176632 Bernardi Jan 1993 A
5190522 Wojcicki et al. Mar 1993 A
5250027 Lewis et al. Oct 1993 A
5261882 Sealfon et al. Nov 1993 A
5314412 Rex May 1994 A
5335994 Weynant Nee Girones Aug 1994 A
5338157 Blomquist Aug 1994 A
5342180 Daoud Aug 1994 A
5348539 Herskowitz Sep 1994 A
5395340 Lee Mar 1995 A
5411487 Castagna May 1995 A
5545143 Fischell Aug 1996 A
5551850 Williamson et al. Sep 1996 A
5569186 Lord et al. Oct 1996 A
5626566 Petersen et al. May 1997 A
5637095 Nason et al. Jun 1997 A
5665065 Colman et al. Sep 1997 A
5741216 Hemmingsen et al. Apr 1998 A
5772635 Dastur et al. Jun 1998 A
5816306 Giacomel Oct 1998 A
5852803 Ashby, III et al. Dec 1998 A
5919167 Mulhauser et al. Jul 1999 A
5925018 Ungerstedt Jul 1999 A
5928201 Poulsen et al. Jul 1999 A
5947934 Hansen et al. Sep 1999 A
5951530 Steengaard et al. Sep 1999 A
5957889 Poulsen et al. Sep 1999 A
5984894 Poulsen et al. Nov 1999 A
5984897 Petersen et al. Nov 1999 A
5997475 Bortz Dec 1999 A
6003736 Ljunggren Dec 1999 A
6010485 Buch-Rasmussen et al. Jan 2000 A
6033377 Rasmussen et al. Mar 2000 A
6045537 Klitmose Apr 2000 A
6074372 Hansen Jun 2000 A
6110149 Klitgaard et al. Aug 2000 A
6156014 Petersen et al. Dec 2000 A
6171276 Lippe et al. Jan 2001 B1
6231540 Smedegaard May 2001 B1
6248067 Causey, III et al. Jun 2001 B1
6248090 Jensen et al. Jun 2001 B1
6248093 Moberg Jun 2001 B1
6277098 Klitmose et al. Aug 2001 B1
6302855 Lav et al. Oct 2001 B1
6302869 Klitgaard Oct 2001 B1
6305908 Hermann et al. Oct 2001 B1
6375638 Nason et al. Apr 2002 B2
6379339 Klitgaard et al. Apr 2002 B1
6381496 Meadows et al. Apr 2002 B1
6404098 Kayama et al. Jun 2002 B1
6427088 Bowman, IV et al. Jul 2002 B1
6461331 Van Antwerp Oct 2002 B1
6474219 Klitmose et al. Nov 2002 B2
6485461 Mason et al. Nov 2002 B1
6508788 Preuthun Jan 2003 B2
6524280 Hansen et al. Feb 2003 B2
6533183 Aasmul et al. Mar 2003 B2
6537251 Klitmose Mar 2003 B2
6540672 Simonsen et al. Apr 2003 B1
6544229 Danby et al. Apr 2003 B1
6547764 Larsen et al. Apr 2003 B2
6551276 Mann et al. Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6554800 Nezhadian et al. Apr 2003 B1
6558320 Causey, III et al. May 2003 B1
6558351 Steil et al. May 2003 B1
6562001 Lebel et al. May 2003 B2
6562011 Buch-Rasmussen et al. May 2003 B1
6564105 Starkweather et al. May 2003 B2
6569126 Poulsen et al. May 2003 B1
6571128 Lebel et al. May 2003 B2
6577899 Lebel et al. Jun 2003 B2
6582404 Klitgaard et al. Jun 2003 B1
6585644 Lebel et al. Jul 2003 B2
6585699 Ljunggreen et al. Jul 2003 B2
6605067 Larsen Aug 2003 B1
6613019 Munk Sep 2003 B2
6641533 Causey, III et al. Nov 2003 B2
6648821 Lebel et al. Nov 2003 B2
6650951 Jones et al. Nov 2003 B1
6656158 Mahoney et al. Dec 2003 B2
6656159 Flaherty Dec 2003 B2
6659948 Lebel et al. Dec 2003 B2
6659978 Kasuga et al. Dec 2003 B1
6659980 Moberg et al. Dec 2003 B2
6663602 Møller Dec 2003 B2
6668196 Villegas et al. Dec 2003 B1
6669669 Flaherty et al. Dec 2003 B2
6687546 Lebel et al. Feb 2004 B2
6691043 Ribeiro, Jr. Feb 2004 B2
6692457 Flaherty Feb 2004 B2
6692472 Hansen et al. Feb 2004 B2
6694191 Starkweather et al. Feb 2004 B2
6699218 Flaherty et al. Mar 2004 B2
6702779 Connelly et al. Mar 2004 B2
6715516 Ohms et al. Apr 2004 B2
6716198 Larsen Apr 2004 B2
6723072 Flaherty et al. Apr 2004 B2
6733446 Lebel et al. May 2004 B2
6736796 Shekalim May 2004 B2
6740059 Flaherty May 2004 B2
6740072 Starkweather et al. May 2004 B2
6740075 Lebel et al. May 2004 B2
6744350 Blomquist Jun 2004 B2
6749587 Flaherty Jun 2004 B2
6752787 Causey, III et al. Jun 2004 B1
6758810 Lebel et al. Jul 2004 B2
6768425 Flaherty et al. Jul 2004 B2
6780156 Haueter et al. Aug 2004 B2
6786246 Ohms et al. Sep 2004 B2
6786890 Preuthun et al. Sep 2004 B2
6796970 Klitmose et al. Sep 2004 B1
6799149 Hartlaub Sep 2004 B2
6809653 Mann et al. Oct 2004 B1
6810290 Lebel et al. Oct 2004 B2
6811533 Lebel et al. Nov 2004 B2
6811534 Bowman, IV et al. Nov 2004 B2
6813519 Lebel et al. Nov 2004 B2
6827702 Lebel et al. Dec 2004 B2
6830558 Flaherty et al. Dec 2004 B2
6852104 Blomquist Feb 2005 B2
6854620 Ramey Feb 2005 B2
6854653 Eilersen Feb 2005 B2
6855129 Jensen et al. Feb 2005 B2
6872200 Mann et al. Mar 2005 B2
6873268 Lebel et al. Mar 2005 B2
6878132 Kipfer Apr 2005 B2
6893415 Madsen et al. May 2005 B2
6899695 Herrera May 2005 B2
6899699 Enggaard May 2005 B2
6922590 Whitehurst Jul 2005 B1
6936006 Sabra Aug 2005 B2
6936029 Mann et al. Aug 2005 B2
6945961 Miller et al. Sep 2005 B2
6948918 Hansen Sep 2005 B2
6950708 Bowman, IV et al. Sep 2005 B2
6960192 Flaherty et al. Nov 2005 B1
6979326 Mann et al. Dec 2005 B2
6997911 Klitmose Feb 2006 B2
6997920 Mann et al. Feb 2006 B2
7005078 Van Lintel et al. Feb 2006 B2
7008399 Larson et al. Mar 2006 B2
7014625 Bengtsson Mar 2006 B2
7018360 Flaherty et al. Mar 2006 B2
7025743 Mann Apr 2006 B2
7029455 Flaherty Apr 2006 B2
7054836 Christensen et al. May 2006 B2
7104972 Møller et al. Sep 2006 B2
7128727 Flaherty et al. Oct 2006 B2
7133329 Skyggebjerg et al. Nov 2006 B2
7232423 Mernoe Jun 2007 B2
20010056262 Cabiri et al. Dec 2001 A1
20020004651 Ljunggreen et al. Jan 2002 A1
20020007154 Hansen et al. Jan 2002 A1
20020040208 Flaherty et al. Apr 2002 A1
20020091358 Klitmose Jul 2002 A1
20020126036 Flaherty et al. Sep 2002 A1
20030055380 Flaherty Mar 2003 A1
20030065308 Lebel et al. Apr 2003 A1
20030088238 Poulsen May 2003 A1
20030199825 Flaherty Oct 2003 A1
20030216683 Shekalim Nov 2003 A1
20040010207 Flaherty et al. Jan 2004 A1
20040019325 Shekalim Jan 2004 A1
20040064088 Gorman et al. Apr 2004 A1
20040064096 Flaherty et al. Apr 2004 A1
20040078028 Flaherty et al. Apr 2004 A1
20040087894 Flaherty May 2004 A1
20040092865 Flaherty et al. May 2004 A1
20040092878 Flaherty May 2004 A1
20040116866 Gorman et al. Jun 2004 A1
20040127844 Flaherty Jul 2004 A1
20040153032 Garribotto et al. Aug 2004 A1
20040171983 Sparks et al. Sep 2004 A1
20040176727 Shekalim Sep 2004 A1
20040204673 Flaherty Oct 2004 A1
20040220551 Flaherty et al. Nov 2004 A1
20040235446 Flaherty et al. Nov 2004 A1
20040260233 Garibotto et al. Dec 2004 A1
20050021005 Flaherty et al. Jan 2005 A1
20050022274 Campbell et al. Jan 2005 A1
20050065760 Murtfeldt et al. Mar 2005 A1
20050090808 Malave et al. Apr 2005 A1
20050095063 Fathallah May 2005 A1
20050160858 Mernoe Jul 2005 A1
20050171512 Flaherty Aug 2005 A1
20050182366 Vogt et al. Aug 2005 A1
20050192561 Mernoe Sep 2005 A1
20050203461 Flaherty et al. Sep 2005 A1
20050215982 Malave et al. Sep 2005 A1
20050222645 Malave et al. Oct 2005 A1
20050238507 DiIanni et al. Oct 2005 A1
20050245878 Mernoe et al. Nov 2005 A1
20050251097 Mernoe Nov 2005 A1
20050267402 Stewart et al. Dec 2005 A1
20050273059 Mernoe et al. Dec 2005 A1
20060041229 Garibotto et al. Feb 2006 A1
20060069382 Pedersen Mar 2006 A1
20060074381 Malave et al. Apr 2006 A1
20060095014 Ethelfeld May 2006 A1
20060135913 Ethelfeld Jun 2006 A1
20060142698 Ethelfeld Jun 2006 A1
20060178633 Garibotto et al. Aug 2006 A1
20060184119 Remde et al. Aug 2006 A1
20060200073 Radmer et al. Sep 2006 A1
20060206054 Shekalim Sep 2006 A1
20060247581 Pedersen et al. Nov 2006 A1
20070073228 Mernoe et al. Mar 2007 A1
20070073236 Mernoe et al. Mar 2007 A1
20070124002 Estes et al. May 2007 A1
20070156092 Estes et al. Jul 2007 A1
20070167905 Estes et al. Jul 2007 A1
20070167912 Causey et al. Jul 2007 A1
Foreign Referenced Citations (40)
Number Date Country
2543545 May 2005 CA
196 27 619 Jan 1998 DE
102 36 669 Feb 2004 DE
0 496 141 Jul 1992 EP
0 612 004 Aug 1994 EP
0 580 723 Oct 1995 EP
1 045 146 Oct 2000 EP
1 136 698 Sep 2001 EP
1 177 802 Feb 2002 EP
0 721 358 May 2002 EP
1 495 775 Jan 2005 EP
1 527 792 May 2005 EP
1 754 498 Feb 2007 EP
2 585 252 Jan 1987 FR
747 701 Apr 1956 GB
2 218 831 Nov 1989 GB
WO 9015928 Dec 1990 WO
WO 9721457 Jun 1997 WO
WO 9811927 Mar 1998 WO
WO 9857683 Dec 1998 WO
WO 9921596 May 1999 WO
WO 9939118 Aug 1999 WO
WO 9948546 Sep 1999 WO
WO 0172360 Oct 2001 WO
WO 0191822 Dec 2001 WO
WO 0191833 Dec 2001 WO
WO 0240083 May 2002 WO
WO 02057627 Jul 2002 WO
WO 02100469 Dec 2002 WO
WO 03103763 Dec 2003 WO
WO 2004056412 Jul 2004 WO
WO 2004110526 Dec 2004 WO
WO 2005002652 Jan 2005 WO
WO 2005039673 May 2005 WO
WO 2005039763 May 2005 WO
WO 2005072794 Aug 2005 WO
WO 2005072795 Aug 2005 WO
WO 2006105792 Oct 2006 WO
WO 2006105793 Oct 2006 WO
WO 2006105794 Oct 2006 WO
Related Publications (1)
Number Date Country
20050245878 A1 Nov 2005 US
Continuations (1)
Number Date Country
Parent PCT/DK03/00753 Nov 2003 US
Child 11121708 US